136 related articles for article (PubMed ID: 32925168)
21. Elevated IL18 levels in Nasopharyngeal carcinoma induced PD-1 expression on NK cells in TILS leading to poor prognosis.
Liou AK; Soon G; Tan L; Peng Y; Cher BM; Goh BC; Wang S; Lim CM
Oral Oncol; 2020 May; 104():104616. PubMed ID: 32151994
[TBL] [Abstract][Full Text] [Related]
22. The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity.
Jang JH; Janker F; De Meester I; Arni S; Borgeaud N; Yamada Y; Gil Bazo I; Weder W; Jungraithmayr W
Carcinogenesis; 2019 Apr; 40(2):324-334. PubMed ID: 30698677
[TBL] [Abstract][Full Text] [Related]
23. Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case study.
Kokowski K; Stangl S; Seier S; Hildebrandt M; Vaupel P; Multhoff G
Strahlenther Onkol; 2019 Apr; 195(4):352-361. PubMed ID: 30747241
[TBL] [Abstract][Full Text] [Related]
24. Functional and metabolic targeting of natural killer cells to solid tumors.
Wang J; Matosevic S
Cell Oncol (Dordr); 2020 Aug; 43(4):577-600. PubMed ID: 32488848
[TBL] [Abstract][Full Text] [Related]
25. PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress.
Klopotowska M; Bajor M; Graczyk-Jarzynka A; Kraft A; Pilch Z; Zhylko A; Firczuk M; Baranowska I; Lazniewski M; Plewczynski D; Goral A; Soroczynska K; Domagala J; Marhelava K; Slusarczyk A; Retecki K; Ramji K; Krawczyk M; Temples MN; Sharma B; Lachota M; Netskar H; Malmberg KJ; Zagozdzon R; Winiarska M
Cancer Immunol Res; 2022 Feb; 10(2):228-244. PubMed ID: 34853030
[TBL] [Abstract][Full Text] [Related]
26. 5-Fluorouracil and interleukin-2 immunochemotherapy enhances immunogenicity of non-small cell lung cancer A549 cells through upregulation of NKG2D ligands.
Zhao L; Wang WJ; Zhang JN; Zhang XY
Asian Pac J Cancer Prev; 2014; 15(9):4039-44. PubMed ID: 24935593
[TBL] [Abstract][Full Text] [Related]
27. Tanshinone IIA enhances susceptibility of non-small cell lung cancer cells to NK cell-mediated lysis by up-regulating ULBP1 and DR5.
Sun Y; Gong C; Ni Z; Hu D; Ng W; Zhu X; Wang L; Si G; Yan X; Zhao C; Yao C; Zhu S
J Leukoc Biol; 2021 Aug; 110(2):315-325. PubMed ID: 33909909
[TBL] [Abstract][Full Text] [Related]
28. Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control.
Sanseviero E; O'Brien EM; Karras JR; Shabaneh TB; Aksoy BA; Xu W; Zheng C; Yin X; Xu X; Karakousis GC; Amaravadi RK; Nam B; Turk MJ; Hammerbacher J; Rubinstein MP; Schuchter LM; Mitchell TC; Liu Q; Stone EL
Cancer Immunol Res; 2019 Aug; 7(8):1371-1380. PubMed ID: 31239316
[TBL] [Abstract][Full Text] [Related]
29. Grain-sized moxibustion promotes NK cell antitumour immunity by inhibiting adrenergic signalling in non-small cell lung cancer.
Hu D; Shen W; Gong C; Fang C; Yao C; Zhu X; Wang L; Zhao C; Zhu S
J Cell Mol Med; 2021 Mar; 25(6):2900-2908. PubMed ID: 33506637
[TBL] [Abstract][Full Text] [Related]
30. Natural killer (NK)-resistant human lung cancer cells are lysed by recombinant interleukin-2-activated NK cells.
Robinson BW; Morstyn G
Cell Immunol; 1987 May; 106(2):215-22. PubMed ID: 3494538
[TBL] [Abstract][Full Text] [Related]
31. Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer.
Cho YH; Choi MG; Kim DH; Choi YJ; Kim SY; Sung KJ; Lee JC; Kim SY; Rho JK; Choi CM
Target Oncol; 2020 Apr; 15(2):241-247. PubMed ID: 32285316
[TBL] [Abstract][Full Text] [Related]
32. Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy?
Ben-Shmuel A; Biber G; Barda-Saad M
Front Immunol; 2020; 11():275. PubMed ID: 32153582
[TBL] [Abstract][Full Text] [Related]
33. The breast tumor microenvironment alters the phenotype and function of natural killer cells.
Krneta T; Gillgrass A; Chew M; Ashkar AA
Cell Mol Immunol; 2016 Sep; 13(5):628-39. PubMed ID: 26277898
[TBL] [Abstract][Full Text] [Related]
34. Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity.
Pasero C; Gravis G; Guerin M; Granjeaud S; Thomassin-Piana J; Rocchi P; Paciencia-Gros M; Poizat F; Bentobji M; Azario-Cheillan F; Walz J; Salem N; Brunelle S; Moretta A; Olive D
Cancer Res; 2016 Apr; 76(8):2153-65. PubMed ID: 27197252
[TBL] [Abstract][Full Text] [Related]
35. NK Cell-Dependent Growth Inhibition of Lewis Lung Cancer by Yu-Ping-Feng, an Ancient Chinese Herbal Formula.
Luo Y; Wu J; Zhu X; Gong C; Yao C; Ni Z; Wang L; Ni L; Li Y; Zhu S
Mediators Inflamm; 2016; 2016():3541283. PubMed ID: 27034590
[TBL] [Abstract][Full Text] [Related]
36. NK cell-based therapeutics for lung cancer.
Pockley AG; Vaupel P; Multhoff G
Expert Opin Biol Ther; 2020 Jan; 20(1):23-33. PubMed ID: 31714156
[No Abstract] [Full Text] [Related]
37. TNF-α-induced Tim-3 expression marks the dysfunction of infiltrating natural killer cells in human esophageal cancer.
Zheng Y; Li Y; Lian J; Yang H; Li F; Zhao S; Qi Y; Zhang Y; Huang L
J Transl Med; 2019 May; 17(1):165. PubMed ID: 31109341
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of tumor cells escaping from immune surveillance of NK cells.
Ge Z; Wu S; Zhang Z; Ding S
Immunopharmacol Immunotoxicol; 2020 Jun; 42(3):187-198. PubMed ID: 32223464
[TBL] [Abstract][Full Text] [Related]
39. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
Gaggero S; Witt K; Carlsten M; Mitra S
Front Immunol; 2020; 11():621225. PubMed ID: 33584718
[TBL] [Abstract][Full Text] [Related]
40. Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors.
Melaiu O; Lucarini V; Cifaldi L; Fruci D
Front Immunol; 2019; 10():3038. PubMed ID: 32038612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]